Proposal for EU E-Cigarette Tax as Part of Tobacco Amendments

Dec.04.2022
Proposal for EU E-Cigarette Tax as Part of Tobacco Amendments
European Union proposes e-cigarette tax as part of tobacco tax reform to create a coordinated tax framework across member states.

A draft document from the EU Commission indicates that the EU is considering proposing a tax on electronic cigarettes as part of a tobacco tax amendment, which would also double the consumption tax in low-tax member countries.


As of now, the tax situation within the European Union has been fragmented due to different member states imposing different tax rates on different products. While e-cigarette products are regulated under the Tobacco Products Directive (TPD) for their health aspects, there still isn't a pan-European tax framework established for them. In 2017, the European Commission (EC) called for negotiations on the proposed revisions to the Tobacco Excise Directive (TED), which will include such taxes.


In February 2020, a report from the European Union indicated that the development of new electronic cigarettes, heated tobacco products, and modern products containing nicotine or cannabis is accelerating within the internal market. The report noted that the current tax and regulatory frameworks for these products lack coordination, which limits the ability to monitor their market growth and control their movement.


As a result, the proposed tax amendment will increase the European Union's minimum consumption tax on cigarettes from €1.80 per pack to €3.60 per pack, raising prices in Eastern European countries where cigarettes cost less than €3. For example, Hungary has been gradually increasing its local tobacco tax, making these products unaffordable for most locals. This comes after the European Commission was brought before the European Court in 2019 for failing to apply minimum excise duties on cigarettes.


Furthermore, the European Union's 2011 Tobacco Tax Directive update will impose taxes on innovative nicotine products such as electronic cigarettes and heated tobacco. One key feature of this tax is that more powerful electronic cigarette products will be subject to a tax of at least 40%, while lower powered products will face a fee of 20%. Heated tobacco products will also be impacted with a tax rate of 55%, collecting €91 in taxes for every 1000 goods sold.


2FIRSTS will continue to report on this issue, with further updates available on the '2FIRSTS APP'. Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

2Firsts Feature | The “Pink Tax” in Vaping: How Women-Centric Design and Pricing Are Recasting the Competitive Landscape
2Firsts Feature | The “Pink Tax” in Vaping: How Women-Centric Design and Pricing Are Recasting the Competitive Landscape
Overseas e-cig brands are embracing “for her” designs, turning devices into fashion accessories. 2Firsts notes a new “pink tax” emerging through design and pricing, reflecting shifting gender and branding strategies.
Oct.20
Product | FASTA Unveils New U.S. Offering, Citing “Made in USA” Status and Texas Compliance
Product | FASTA Unveils New U.S. Offering, Citing “Made in USA” Status and Texas Compliance
FASTA has launched a new disposable, the FASTA ALIEN 51K, on U.S. online channels. Retailer Mi-Pod describes the product as “assembled and filled in the U.S.” and labels it as compliant with Texas e-cigarette registration requirements. The ALIEN 51K is now available via Mi-Pod and Vaping, with a suggested retail price of about $19.99.
Nov.12 by 2FIRSTS.ai
Two Malaysian Men Charged Over Illegal Import of  Vape Items at Singapore Checkpoint
Two Malaysian Men Charged Over Illegal Import of Vape Items at Singapore Checkpoint
Two Malaysian men arrested for illegally importing e-cigarettes at Woodlands Checkpoint, facing charges, court hearing on December 15. (20 words)
Nov.18 by 2FIRSTS.ai
India’s NUSRL Hosts National Consultation on Protection from Emerging Tobacco and Nicotine Products
India’s NUSRL Hosts National Consultation on Protection from Emerging Tobacco and Nicotine Products
The National University of Study and Research in Law (NUSRL) in Ranchi, together with national and international public health experts, held a consultation focused on youth protection, enforcement capacity, and the regulatory landscape for emerging nicotine products. State Health Minister Irfan Ansari called for stronger policies and coordinated efforts to prevent addiction.
Dec.02
South Korea Implements Law Requiring Full Disclosure of Tobacco Harmful Substances
South Korea Implements Law Requiring Full Disclosure of Tobacco Harmful Substances
South Korea has enacted the Tobacco Harm Management Act, effective November 1, 2025, requiring tobacco manufacturers and importers to test and report harmful substances in their products every two years. Results for all tobacco types—including combustible cigarettes, heated tobacco, and e-cigarettes—will be publicly available from mid-2026.
Nov.04 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai